Clinical Trial Update: Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov entry for a phase 2/3 trial comparing toremifene versus tamoxifen in premenopausal patients with ER/PR-positive breast cancer; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)
• Toremifene (toremifene)

Snippet

Sponsor: Fengxi Su | Conditions: Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor Positive | Phase 2, Phase 3 | Status: UNKNOWN